GlaxoSmithKline: all 4,196 studies
Page 11 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Patch Test of Benzalkonium Chloride Disinfectant SprayCompletedNCT01762982Not applicableResults posted
- Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcgCompletedNCT01762800Phase 4Results posted
- Paracetamol With Caffeine to Treat Episodic Tension Type HeadacheTerminatedNCT01755702Phase 2/3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young AdultsCompletedNCT01755689Phase 3Results posted
- Bioequivalence Study of Albendazole 400 mg Tablets in Chinese PopulationCompletedNCT01755637Phase 1Results posted
- Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in AdultsCompletedNCT01755598Phase 2Results posted
- Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral SclerosisCompletedNCT01753076Phase 2Results posted
- An Efficacy Study of Chlorhexidine MouthwashesCompletedNCT01751178Phase 4Results posted
- Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or OlderCompletedNCT01751165Phase 3Results posted
- An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in BrazilTerminatedNCT01751139Not applicableResults posted
- A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese SubjectsCompletedNCT01751113Phase 4Results posted
- This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.CompletedNCT01750931Not applicableResults posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal InfectionCompletedNCT01746108Phase 3Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young AdultsCompletedNCT01738477Phase 3Results posted
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01733758Phase 3Results posted
- Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT01733238Phase 2Results posted
- Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years OldCompletedNCT01730378Phase 4Results posted
- Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistryCompletedNCT01729455Results posted
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 DiabetesCompletedNCT01725126Phase 2Results posted
- Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset SeizuresTerminatedNCT01721317Phase 4Results posted
- Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)CompletedNCT01716533Not applicableResults posted
- Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcgCompletedNCT01716520Phase 3Results posted
- Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of AgeCompletedNCT01711736Phase 3Results posted
- BE Study of Metformin GSK 500mgCompletedNCT01710527Phase 2Results posted
- A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01706328Phase 3Results posted
- U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With AcneCompletedNCT01706263Phase 4Results posted
- U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™CompletedNCT01706250Phase 4Results posted
- An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaCompletedNCT01706198Phase 3Results posted
- Belimumab Assessment of Safety in SLECompletedNCT01705977Phase 4Results posted
- Nicotine Mouth Film for Craving Relief.CompletedNCT01702532Phase 3Results posted
- A Pharmacokinetic Evaluation of Two Nicotine Patches in SmokersCompletedNCT01702519Phase 1Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345CompletedNCT01702454Phase 3Results posted
- Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3Results posted
- Long-term Safety Study for GSK573719 in JapaneseCompletedNCT01702363Phase 3Results posted
- RELOVAIR® Lung Deflation StudyCompletedNCT01691885Phase 3Results posted
- MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic SubjectsCompletedNCT01691859Phase 3Results posted
- A Study in Adolescent Females to Explore Cytomegalovirus InfectionCompletedNCT01691820Not applicableResults posted
- Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal HypersensitivityCompletedNCT01691560Phase 2Results posted
- Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory AsthmaCompletedNCT01691521Phase 3Results posted
- Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory AsthmaCompletedNCT01691508Phase 3Results posted
- A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and IpratropiumCompletedNCT01691482Phase 4Results posted
- Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of AsthmaCompletedNCT01687296Phase 3Results posted
- Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent AsthmaCompletedNCT01687283Phase 3Results posted
- Effects of Two Doses of a Common Cold Treatment on AlertnessCompletedNCT01686646Phase 3Results posted
- An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.CompletedNCT01686633Phase 3Results posted
- Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.CompletedNCT01682876Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3Results posted
- Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic HyperplasiaTerminatedNCT01673490Phase 4Results posted
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.CompletedNCT01669122Phase 2Results posted
- Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342CompletedNCT01669096Phase 2Results posted
- Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGSTerminatedNCT01668654Phase 3Results posted
- Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.CompletedNCT01663714Phase 2Results posted
- Belimumab in Remission of VASculitisCompletedNCT01663623Phase 3Results posted
- Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental ErosionCompletedNCT01657903Not applicableResults posted
- Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate DentifriceCompletedNCT01657877Phase 2Results posted
- An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore EpisodeCompletedNCT01653509Phase 1Results posted
- Pediatric Lupus Trial of Belimumab Plus Background Standard TherapyCompletedNCT01649765Phase 2Results posted
- Dose Ranging of GSK2336805 in Combination TherapyCompletedNCT01648140Phase 2Results posted
- Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset SeizuresTerminatedNCT01648101Phase 3Results posted
- Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus RilpivirineCompletedNCT01641809Phase 2Results posted
- A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With AsthmaCompletedNCT01641692Phase 2Results posted
- Effect of Fluoride in a Dentifrice on Remineralization of Erosive LesionsCompletedNCT01641237Phase 3Results posted
- Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™CompletedNCT01641133Phase 3Results posted
- Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy SubjectsCompletedNCT01641042Phase 3Results posted
- Efficacy and Safety of Belimumab in Patients With Active Lupus NephritisCompletedNCT01639339Phase 3Results posted
- Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected PatientsCompletedNCT01636778Phase 2Results posted
- A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPDCompletedNCT01636713Phase 3Results posted
- Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01632241Phase 4Results posted
- Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01630135Phase 3Results posted
- Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years OldCompletedNCT01627561Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes MellitusCompletedNCT01627340Phase 4Results posted
- Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular DiseaseCompletedNCT01627327Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in AdultsCompletedNCT01626820Phase 3Results posted
- Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01622231Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3Results posted
- Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy InfantsCompletedNCT01616459Phase 2Results posted
- A Study of Belimumab in Idiopathic Membranous GlomerulonephropathyCompletedNCT01610492Phase 2Results posted
- Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected SubjectsCompletedNCT01610427Not applicableResults posted
- Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173ACompletedNCT01610414Phase 3Results posted
- A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries ModelCompletedNCT01607411Phase 3Results posted
- ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01607398Phase 4Results posted
- An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset SeizuresTerminatedNCT01607346Phase 4Results posted
- A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and AboveCompletedNCT01607112Phase 3Results posted
- Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation PatientsCompletedNCT01602562Phase 3Results posted
- A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric EmptyingCompletedNCT01602549Phase 2Results posted
- Lamotrigine Phase III Study in Bipolar I DisorderCompletedNCT01602510Phase 3Results posted
- Pertussis Infection in Adolescents and Adults With Prolonged CoughCompletedNCT01597687Not applicableResults posted
- The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung InjuryCompletedNCT01597635Phase 2Results posted
- BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115CompletedNCT01597622Phase 3Results posted
- A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01597492Phase 4Results posted
- The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal HypersensitivityCompletedNCT01592864Phase 3Results posted
- Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal HypersensitivityCompletedNCT01592851Phase 3Results posted
- Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in SpainCompletedNCT01592799Not applicableResults posted
- The Effects of Potassium Nitrate in Reducing Dentinal HypersensitivityCompletedNCT01587950Phase 1Results posted
- 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney DiseaseCompletedNCT01587924Phase 2Results posted
- 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing DialysisCompletedNCT01587898Phase 2Results posted
- A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other CancersCompletedNCT01587703Phase 1Results posted
- Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With StrabismusCompletedNCT01584843Phase 3Results posted
- Study of Belimumab Administered Subcutaneously to Healthy SubjectsCompletedNCT01583530Phase 1Results posted
- Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese ToddlersCompletedNCT01577732Phase 3Results posted